Member Info for TrickyEFC

Steven Myers is the founder and former CEO of the large aerospace and defense management consulting firm, Steven Myers & Associates (SM&A). He is also an entrepreneur, international bestselling author [citation needed], and keynote business speaker who is very active in public service efforts. Steven lectures frequently about being an entrepreneur at USC Marshall School of Business where he speaks about topics such as business competition

Gonna be a really interesting year here

William Potts

23.17 %

Oberon Investments Ltd. (GB Investment Management)

8.188 %

Nicholas Nelson

7.296 %

Stuart Sharpless

6.31 %

Paul Levinson

3.267 %

Victor Bolduev

2.308 %

Roby Zomer

0.7214 %

Craig Burton

0.6069 %

Brett Mitchell

0.3427 %

William Murray Mitchell

0.3427 %

I have been waiting for one of those holdings RNs since the last one.

That's over 50% off company shares off market

Another buyer.

That's fooking brilliant

They covered this bit though 😁

Dr. Crome's strategic leadership has been pivotal in the commercialisation of several blockbuster drugs, including leading the prioritisation of Avastin® and Tamiflu®, resulting in rapid regulatory approvals and the realisation of US$7 billion and US$3 billion peak annual sales respectively for Roche.

She joined Cancer Research UK in 2015 to head up the Study, Project and Portfolio Management Group management group responsible for the in-licensing and development of a portfolio of approximately 25 oncology products

Dr. Crome has guided more than 100 novel therapies from early-stage research to first-in-human clinical trials.

What a strong looking team.l top credentials all round.

Remember it's no secret.

The phase 2 results also demonstrated an on average 86% abstinence rate in the 6 months post treatment versus 2% abstinence pre-trial.

Morning.

Another big player joins the team.

Avengers assemble 😂😂

Money in the bank left too.

Let's have another investment set in motion.

The Company will use part of the cash inflow from the Disposal to settle the remaining outstanding loan notes amounting to circa £800,000, and the accrued interest thereon. A further announcement will be made in due course upon receipt of the proceeds from the Disposal

More millions.

They buys then?

Some million buys showing now

bobat it has a lil bit. plus still the avo to go which should have allowed the nob head sellers tomleave and we can move on up.

if not **** it all 😂😂😂😂

i know bubble but ffs.

we gapped up on open .

who the **** tards selling.

grrrr got no patience today with this 😂😂😈😈

how is this still under 1p.

seller ******s 😂😂😂😂😂

Cheers bones.

I am gonna email them this week and ask them about the following

Grant of Haemostatic Hydrogel Patent

The Company is pleased to announce the grant of patent P-202400066, titled "Dual hydrogel multi-crosslinking haemostatic composition and method of manufacturing thereof", to further strengthen the Company's IP portfolio.

The disclosed dual hydrogel multi-crosslinking haemostatic composition offers a groundbreaking solution for emergency haemostasis by amalgamating two distinct gels, each possessing unique cross-linking mechanisms and bioactive components. Gel A, containing sodium carboxymethylcellulose (Na-CMC) and tranexamic acid (TXA), is ionically cross-linked with calcium ions (Ca+), while Gel B, comprising cationic carboxymethyl chitosan (CMCS) and sodium alginate (Na-Alginate), undergoes electrostatic and ionic cross-linking with boron ions (B-).

Stored separately but applied together using a dual-chamber syringe, these gels intermix at the bleeding site, facilitating immediate formation of a final hydrogel with enhanced mechanical properties and adhesive strength.

This composition fulfils the imperative for effective, user-friendly haemostatic agents in emergency settings, offering biocompatibility, antibacterial properties, and pro-healing effects, thereby presenting a versatile solution for various surgical procedures, trauma care, and veterinary medicine, while also serving as a potential scaffold for tissue engineering or drug delivery.

Can ya sell or are these drip sell orders.

Early in the day. Should be a lot higher this avo